Skip to main content
Contact
Login
Our Company
Our Company
Mission
Leadership
Clinical Studies
Clinical Studies
ECLIPSE
GRECO-Breast Cancer
Solutions
Solutions
Treatment Selection
Residual Disease & Recurrence Monitoring
Early Detection
Biopharma Solutions
International
Investors
Investors
Media
Media
Press Releases
Resources and Media Assets
Contacts
Careers
Careers
Join Our Mission
Jobs
Press Releases
Investors Menu
Home
Press Releases
Events & Presentations
Events
Presentations
Stock Information
Stock Quote & Chart
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEC Filings
Corporate Governance
Governance Documents
Leadership
Board of Directors
Committee Composition
ESG
Resources
Investor FAQs
Investor Email Alerts
Investor Contacts
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2023
2022
2021
2020
2019
2018
2017
November 16, 2017
Guardant Health Expands Support for the Development of the GuardantOMNI™ Assay Through New Agreement with Bristol-Myers Squibb
November 15, 2017
New Research Reveals Molecular Heterogeneity of Metastatic Gastroesophageal Cancer
November 6, 2017
Guardant Health Database Reveals Potential of Targeted Therapy Combinations to Treat Advanced Lung Cancer
October 2, 2017
Study Demonstrates Potential for the Guardant360 Assay® to Predict Which Patients Will Benefit from Immunotherapy
September 26, 2017
Guardant Health Receives Investigational Device Exemption Approval from the FDA to Support Merck KGaA, Darmstadt, Germany Tepotinib Study